Published in Clin Ther on April 01, 1999
Proton pump inhibitors in cirrhosis: tradition or evidence based practice? World J Gastroenterol (2008) 1.00
Identification of the time-point which gives a plasma rabeprazole concentration that adequately reflects the area under the concentration-time curve. Eur J Clin Pharmacol (2006) 0.82
Influence of 1-week Helicobacter pylori eradication therapy with rabeprazole, clarithromycin, and metronidazole on 13C-aminopyrine breath test. Dig Dis Sci (2005) 0.80
PPIs are not associated with a lower incidence of portal-hypertension-related bleeding in cirrhosis. World J Gastroenterol (2010) 0.78
Monitoring cytochrome P-450 activity during rabeprazole treatment in patients with gastresophageal reflux disease. Dig Dis Sci (2006) 0.76
Postmarketing surveillance of rabeprazole in upper gastrointestinal peptic lesions in Japanese patients with coexisting hepatic disorders. Curr Ther Res Clin Exp (2006) 0.75
Famotidine relieves symptoms of gastroesophageal reflux disease and heals erosions and ulcerations. Results of a multicenter, placebo-controlled, dose-ranging study. USA Merck Gastroesophageal Reflux Disease Study Group. Arch Intern Med (1991) 1.55
Double-blind comparison [correction of Double-blind, placebo-controlled comparison] of rabeprazole 20 mg vs. omeprazole 20 mg in the treatment of erosive or ulcerative gastro-oesophageal reflux disease. The European Rabeprazole Study Group. Aliment Pharmacol Ther (1999) 1.07
Pseudomelanosis of the duodenum. Endoscopic and histologic observations on a unique case of pigmentation in the duodenum. Gastrointest Endosc (1980) 0.99
PEGylated therapeutic proteins for haemophilia treatment: a review for haemophilia caregivers. Haemophilia (2012) 0.95
Colonoscopy associated bacteremia. Surg Gynecol Obstet (1976) 0.93
Decreasing oesophageal acid exposure in patients with GERD: a comparison of rabeprazole and omeprazole. Aliment Pharmacol Ther (2001) 0.90
Comparison of rabeprazole 20 mg versus omeprazole 20 mg in the treatment of active duodenal ulcer: a European multicentre study. Aliment Pharmacol Ther (1999) 0.89
Rabeprazole versus omeprazole in preventing relapse of erosive or ulcerative gastroesophageal reflux disease: a double-blind, multicenter, European trial. The European Rabeprazole Study Group. Dig Dis Sci (2000) 0.89
Cardiovascular comorbidities are increased in U.S. patients with haemophilia A: a retrospective database analysis. Haemophilia (2013) 0.88
Rabeprazole, 20 mg once daily or 10 mg twice daily, is equivalent to omeprazole, 20 mg once daily, in the healing of erosive gastrooesophageal reflux disease. Scand J Gastroenterol (2000) 0.88
Effect of different doses of omeprazole on 24-hour oesophageal acid exposure in patients with gastro-oesophageal reflux. Aliment Pharmacol Ther (1991) 0.87
Effect of oral bethanechol on parameters of esophageal peristalsis. Dig Dis Sci (1981) 0.87
Rabeprazole versus ranitidine for the treatment of erosive gastroesophageal reflux disease: a double-blind, randomized clinical trial. Raberprazole Study Group. Am J Gastroenterol (2000) 0.87
Dose--response effect of famotidine on patterns of gastro-oesophageal reflux. Aliment Pharmacol Ther (1988) 0.86
Effects of oral rabeprazole on oesophageal and gastric pH in patients with gastro-oesophageal reflux disease. Aliment Pharmacol Ther (1997) 0.85
A randomized, double-blind trial of the efficacy and safety of 10 or 20 mg rabeprazole compared with 20 mg omeprazole in the maintenance of gastro-oesophageal reflux disease over 5 years. Aliment Pharmacol Ther (2003) 0.85
Comparison of rabeprazole 20 mg vs. omeprazole 20 mg in the treatment of active gastric ulcer--a European multicentre study. The European Rabeprazole Study Group. Aliment Pharmacol Ther (1998) 0.84
Lower esophageal sphincter pressures and serum gastrin levels after cholinergic stimulation. Am J Physiol (1976) 0.84
Pressure profile of esophageal peristalsis in normal humans as measured by direct intraesophageal transducers. Am J Dig Dis (1977) 0.83
Famotidine (20 mg) b.d. relieves gastrooesophageal reflux symptoms in patients without erosive oesophagitis. Famotidine/GERD Investigation Group. Aliment Pharmacol Ther (1991) 0.83
Rabeprazole produces rapid, potent, and long-acting inhibition of gastric acid secretion in subjects with Helicobacter pylori infection. Aliment Pharmacol Ther (2000) 0.82
Mass balance study of [14C] rabeprazole following oral administration in healthy subjects. Int J Clin Pharmacol Ther (2006) 0.82
A unique postmarket outpatient surveillance program of cimetidine: report on phase II and final summary. Am J Gastroenterol (1984) 0.80
An ascending single-dose safety and tolerance study of an oral formulation of rabeprazole (E3810). Aliment Pharmacol Ther (1998) 0.79
Barrett's esophagus: inherited epithelium or inherited reflux? J Clin Gastroenterol (1983) 0.79
The value of duodenal bile examination in the evaluation of persistent pain in the upper part of the abdomen. Surg Gynecol Obstet (1978) 0.79
Rabeprazole: pharmacokinetics and tolerability in patients with stable, end-stage renal failure. J Clin Pharmacol (1999) 0.78
Rabeprazole: pharmacology, pharmacokinetics, and potential for drug interactions. Introduction. Aliment Pharmacol Ther (1999) 0.78
On gastric polyps, proton pump inhibitors and long-term risks. Aliment Pharmacol Ther (2001) 0.75
Treatment strategies for gastroesophageal reflux disease. Clin Ther (2000) 0.75
Gastric glandular cysts: uncommon or unrecognized? Gastrointest Endosc (1982) 0.75
The establishment and validation of the mobile immunization team concept at a clinic level. Mil Med (1991) 0.75
Serum gastrin concentrations following oral bethanechol with and without a meal. Am J Dig Dis (1978) 0.75
A new approach to ventilatory support of infants with respiratory distress syndrome. II. The clinical applications of the Arp Infant Respirator. Anesth Analg (1969) 0.75
A new approach to ventilatory support of infants with respiratory distress syndrome. 1: The Arp infant respirator. Anesth Analg (1969) 0.75
Colonic Crohn's disease. Gastrointest Endosc (1984) 0.75
Lidocaine-cimetidine interaction. Ann Intern Med (1983) 0.75
Effects of long-term medical treatment with cimetidine and bethanechol in patients with esophagitis and Barrett's esophagus. J Clin Gastroenterol (1987) 0.75
Infectious hepatitis and the Guillain-Barré syndrome. J Med Soc N J (1980) 0.75
Barrett's esophagus. Gastrointest Endosc (1982) 0.75
Gastric xanthomata: the need for recognition. J Clin Gastroenterol (1982) 0.75
An electrifying endoscopy (suite) experience. Gastrointest Endosc (1985) 0.75
Patterns of prescribing cimetidine among outpatients. N Engl J Med (1983) 0.75
Report of an Air National Guard clinic's experience with screening at-risk individuals before initial physical fitness testing. Mil Med (1989) 0.75
Rabeprazole is superior to ranitidine in the management of active duodenal ulcer disease: results of a double-blind, randomized North American study. Am J Gastroenterol (2000) 0.75
Review of an extensive worldwide study of a new H2-receptor antagonist, famotidine, as compared to ranitidine in the treatment of acute duodenal ulcer. J Clin Gastroenterol (1987) 0.75
Ranitidine and cimetidine. JAMA (1984) 0.75
Scars without wounds: spectrum of delayed manifestations of histoplasmosis outside of the endemic area. Crit Rev Diagn Imaging (1980) 0.75
A study of the feasibility of modifying standard communications equipment for the telemetering of physiological data under conditions of high heat and humidity. Vol. 18, No. 1. Res Rep U S Nav Med Field Res Lab (1968) 0.75